Three-day-old Swiss mice were infected intraperitoneally with 2 × 104 PFU of the Brazilian ZIKV strain. Treatments with iDGAT-1 were carried out at 2.5 mg/kg/day intraperitoneally and started one day before infection (pretreatment). The same dose was given once daily for the subsequent days throughout the experiment. For comparisons, a mock-infected group of animals was used as a control. Animals were monitored daily for survival and weight gain; euthanasia was performed to alleviate animal suffering when necessary. The criteria for humane endpoint were differences in weight between infected and control groups > 25%, ataxia or rejection of moribund offspring, characterized by no feeding by the female adult mouse.
Free full text: Click here